• WKN: 704230
  • ISIN: DE0007042301
  • Land: Deutschland

Nachricht vom 22.06.2020 | 18:24

RHÖN-KLINIKUM Aktiengesellschaft: Resignation of Chief Executive Officer Stephan Holzinger with immediate effect

DGAP-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Personnel/Miscellaneous
22.06.2020 / 18:24
The issuer is solely responsible for the content of this announcement.


Corporate News

Bad Neustadt / Saale | 22nd June 2020

RHÖN-KLINIKUM AG: Resignation of Chief Executive Officer Stephan Holzinger with immediate effect


Today, the Chairman of the Management Board, Mr. Stephan Holzinger, resigned from his position on the Management Board and other offices within the RHÖN-KLINIKUM Group with immediate effect. The Supervisory Board of RHÖN-KLINIKUM AG has approved the amicable termination of the management service agreement of Mr. Stephan Holzinger with effect as of 30 September 2020.

"The Supervisory Board of RHÖN-KLINIKUM AG would like to thank Stephan Holzinger for his successful work as CEO of the company since 2017, when Mr Holzinger took over the company in a difficult situation. In addition to his success in achieving the "Pact for the Future" with the State of Hesse and the two universities of Giessen and Marburg, he has advanced the development of the company through many entrepreneurial decisions, including those relating to digitalisation, telemedicine and the company's extraordinarily stable financial constitution, which is particularly important in times of crisis."

Stephan Holzinger explains: "In view of the new majority situation and the new direction that is apparently associated with it, this is the best time for me to pass on the responsibility. I would like to thank the Supervisory Board for the trust it has placed in me and wish those responsible every success in shaping the future of the company."


RHÖN‐KLINIKUM AG is one of the largest healthcare providers in Germany. The hospital group offers excellent medical care with a direct link to universities and research institutes. Over 860,000 patients are treated every year at the five group hospitals located in Bad Berka, Bad Neustadt, Frankfurt (Oder), Giessen and Marburg where more than 18,000 employees work. RHÖN-KLINIKUM AG is currently exploiting the opportunities available to develop new areas of growth. Entering the forward-looking telemedicine market with Medgate Deutschland, the innovative RHÖN campus concept for offering avantgarde healthcare across sectoral boundaries in rural areas as well as consistently extending our gradual corporate digitalisation are key pillars of the corporate strategy.

More information under www.rhoen-klinikum-ag.com

Follow us



RHÖN-KLINIKUM AG | Head of Corporate Communications and Marketing
Elke Pfeifer
Telephone: +49 9771 65-12110| E-Mail: elke.pfeifer@rhoen-klinikum-ag.com

RHÖN-KLINIKUM AG | Head of Investor Relations and Treasury
Julian Schmitt
Telephone: +49 9771 65-12250 | E-Mail: julian.schmitt@rhoen-klinikum-ag.com

RHÖN-KLINIKUM AG | Schlossplatz 1 | 97616 Bad Neustadt / Saale, Germany

22.06.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

show this


Anleihe der German Real Estate Capital S.A. stark überdurchschnittlich attraktiv

Die Anleihe der German Real Estate Capital S.A. weist aktuell eine Effektivverzinsung von ca. 14 % auf. Da es sich hier quasi um eine Immobilien-Anleihe handelt, ist das Anleiherisiko überschaubar. Insgesamt verfügt die German Real Estate-Gruppe über 6 Objekte, 24 Bestands- und 22 Handelsobjekte, womit eine Kombination aus stetigen Einnahmen und attraktiven Entwicklerrenditen erreicht wird. Wir stufen die Anleihe als stark überdurchschnittlich attraktiv ein.

News im Fokus

Vonovia SE: Mehr als 150 Talente starten ihre Ausbildung bei Vonovia (News mit Zusatzmaterial)

03. August 2020, 15:52

Aktueller Webcast

TeamViewer AG

Q2 2020 Ergebnis

04. August 2020

Aktuelle Research-Studie

Original-Research: Wolftank-Adisa Holding AG (von Montega AG): Kaufen Wolftank-Adisa Holding AG

03. August 2020